Roger S. Newton

2014

In 2014, Roger S. Newton earned a total compensation of $425K as Executive Chairman and Chief Scientific Officer at Esperion Therapeutics, a 77% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$50,000
Salary$375,000
Total$425,000

Newton received $375K in salary, accounting for 88% of the total pay in 2014.

Newton also received $50K in non-equity incentive plan.

Rankings

In 2014, Roger S. Newton's compensation ranked 10,814th out of 13,032 executives tracked by ExecPay. In other words, Newton earned more than 17.0% of executives.

ClassificationRankingPercentile
All
10,814
out of 13,032
17th
Division
Manufacturing
4,129
out of 4,966
17th
Major group
Chemicals And Allied Products
1,425
out of 1,686
16th
Industry group
Drugs
1,144
out of 1,365
16th
Industry
Pharmaceutical Preparations
875
out of 1,043
16th
Source: SEC filing on March 6, 2017.

Newton's colleagues

We found two more compensation records of executives who worked with Roger S. Newton at Esperion Therapeutics in 2014.

2014

Narendra Lalwani

Esperion Therapeutics

Chief Operating Officer

2014

Tim Mayleben

Esperion Therapeutics

Chief Executive Officer

You may also like